Amyloid and the macrophage: It's all about local production of IL-1β

Diabetes

Volumn 63, Issue 5, 2014, Pages 1448-1450

  Broniowska, Katarzyna A ^a   Corbett, John A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DIABETES MELLITUS, TYPE 2; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; MACROPHAGES;

EID: 84899111253     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0003     Document Type: Note

References (20)

1. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986;232:1545-1547 (Pubitemid 16061563)
2. Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH. Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 1986;41:250-259 (Pubitemid 16039029)
3. Corbett JA, Wang JL, Hughes JH, et al. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 1992;287:229-235
4. Corbett JA, Wang JL, Sweetland MA, Lancaster JR Jr, McDaniel ML. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 1992;90:2384-2391 (Pubitemid 23010057)
5. Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990;276:42-44
6. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167-3173
7. Corbett JA, Lancaster JR Jr, Sweetland MA, McDaniel ML. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem 1991;266:21351-21354 (Pubitemid 121000188)
8. Wang Y, Goodman M, Lumerman J, et al. In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release. Diabetes Res Clin Pract 1989;7:205-211 (Pubitemid 19231482)
9. Wogensen LD, Reimers J, Nerup J, et al. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats. Diabetologia 1992;35:331-339
10. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 1990;87:968-972
11. Takamura T, Kato I, Kimura N, et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J Biol Chem 1998;273:2493-2496 (Pubitemid 28133886)
12. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98-107
13. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851-860
14. Westwell-Roper CY, Ehses JA, Verchere CB. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction. Diabetes 2014;63:1698-1711
15. Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 2010;11:897-904
16. Lacy PE. The intraislet macrophage and type I diabetes. Mt Sinai J Med 1994;61:170-174 (Pubitemid 24159526)
17. Lacy PE, Finke EH. Activation of intraislet lymphoid cells causes destruction of islet cells. Amer J Path 1991;138:1183-1190
18. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 1998;102:516-526 (Pubitemid 28376154)
19. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 1998;160:2684-2691 (Pubitemid 28136719)
20. Corbett JA, McDaniel ML. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 1995;181:559-568